+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Automated Oligonucleotide Synthesizer Market - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 180 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6081163
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The automated oligonucleotide synthesizer market is advancing rapidly, driven by digital integration and evolving biopolymer assembly requirements. Senior leaders across genomics, pharmaceuticals, and diagnostics are adopting next-generation platforms to unlock gains in operational precision and workflow agility.

Market Snapshot: Automated Oligonucleotide Synthesizer Solutions

As a cornerstone technology for molecular engineering, automated oligonucleotide synthesizers are delivering significant value across genomics, therapeutics, and diagnostics. The market is experiencing robust momentum, underpinned by scalable instrument architectures, growing demand for custom synthesis, and the integration of real-time quality controls within biopolymer assembly workflows. These solutions support a widening spectrum of oligonucleotide-based modalities, enabling research and manufacturing teams globally to accelerate innovation while meeting stringent purity and compliance standards.

Scope & Segmentation in the Automated Oligonucleotide Synthesizer Market

  • Product Types: Consumables (phosphoramidites, reagents solvents, solid supports), instruments (benchtop synthesizer, high throughput synthesizer), and services (custom synthesis, maintenance, training).
  • Applications: DNA synthesis (primer, probe, synthetic gene), RNA synthesis (miRNA, mRNA, siRNA), and therapeutic oligonucleotides (antisense, aptamer, siRNA therapeutic).
  • Technologies: Enzymatic synthesis and phosphoramidite synthesis, each offering specific benefits for different sequence complexities and reaction conditions.
  • End Users: Academic institutions, biotechnology companies, contract manufacturing organizations, contract research organizations, and pharmaceutical companies.
  • Scale: Benchtop and high throughput platforms catering to lab project scopes from pilot to large-scale manufacturing.
  • Regions: Americas (including United States, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (with key markets such as United Kingdom, Germany, France, Russia, Italy, Spain, UAE, Saudi Arabia, South Africa, Denmark, Netherlands, Qatar, Finland, Sweden, Nigeria, Egypt, Turkey, Israel, Norway, Poland, Switzerland), and Asia-Pacific (China, India, Japan, Australia, South Korea, Indonesia, Thailand, Philippines, Malaysia, Singapore, Vietnam, Taiwan).
  • Key Companies: Thermo Fisher Scientific Inc., Merck KGaA, Agilent Technologies, Inc., Tecan Group Ltd., Hamilton Company, Inc., Gilson, Inc., BioAutomation, LLC., Biosearch Technologies, Inc., CEM Corporation, and Hitachi High-Tech Corporation.

Key Takeaways for Decision-Makers

  • Automated oligonucleotide synthesizers are shaping precision biopolymer assembly through modular designs, intuitive interfaces, and real-time analytics, optimizing both research and large-scale production environments.
  • The rise of RNA-based therapeutics and advanced antisense modalities is fueling diverse technology adoption, with both enzymatic and phosphoramidite synthesis workflows in active commercial use.
  • Digital solutions—featuring artificial intelligence, remote monitoring, and predictive maintenance—are enabling workflow harmonization across geographically dispersed research consortia.
  • Segmented product strategies, such as custom chemistries and integrated service platforms, enhance value propositions and bolster supplier differentiation.
  • Local reagent production and regional instrument assembly networks are critical in ensuring uninterrupted operations, in light of evolving regulatory and geopolitical dynamics.

Impact of United States Tariffs on Supply Chain and Cost Structures

Revised tariffs in 2025 have introduced complexity, particularly through increased duties on imported phosphoramidites and specialty solvents. Manufacturers and end-users are responding by expanding domestic reagent production, deepening local partnerships, diversifying supplier portfolios, and leveraging bonded warehouse programs. Strategic sourcing decisions are increasingly oriented toward resilience and flexibility, as regional investment patterns shift to accommodate these macroeconomic pressures.

Methodology & Data Sources

This market research leverages a multi-layered approach, including primary interviews with industry stakeholders, secondary data from peer-reviewed journals and financial disclosures, supply chain mapping, and expert panel validation. Data integrity is maintained at each stage, resulting in actionable and reliable market insights.

Why This Report Matters

  • Provides a holistic overview of product segmentation, enabling precise alignment of investment and procurement strategies with organizational objectives.
  • Delivers in-depth analysis of regulatory, technological, and market trends, empowering decision-makers to anticipate risk and act with confidence.
  • Equips leadership with forward-looking strategies to ensure operational sustainability and competitive positioning in a dynamic market.

Conclusion

Automation, digital transformation, and resilient supply chains are reshaping the future of oligonucleotide synthesis. Market leaders embracing these trends stand to secure long-term operational advantage and catalyze breakthrough innovation.



This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Integration of AI-driven synthesis protocols for optimized oligonucleotide yield and purity
5.2. Implementation of cloud-based remote monitoring for real-time instrument performance insights
5.3. Development of modular synthesizer platforms to support diverse chemistry and high throughput
5.4. Adoption of green chemistry approaches to minimize hazardous waste from synthesis processes
5.5. Expansion of single-use reagent cartridges to reduce cross-contamination and streamline workflows
5.6. Customizable synthesis parameters enabling on-demand production of complex modified oligos
5.7. Incorporation of inline quality control sensors for automated detection of synthesis failures
5.8. Partnerships between instrument manufacturers and biopharma to co-develop specialized combinatorial libraries
5.9. Regulatory alignment initiatives to standardize synthetic oligonucleotide quality across global markets
5.10. Advances in microfluidic synthesis modules to accelerate rapid prototyping of therapeutic sequences
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Automated Oligonucleotide Synthesizer Market, by Product Type
8.1. Introduction
8.2. Consumables
8.2.1. Phosphoramidites
8.2.2. Reagents Solvents
8.2.3. Solid Supports
8.3. Instruments
8.3.1. Benchtop Synthesizer
8.3.2. High Throughput Synthesizer
8.4. Services
8.4.1. Custom Synthesis Service
8.4.2. Maintenance Service
8.4.3. Training Service
9. Automated Oligonucleotide Synthesizer Market, by Application
9.1. Introduction
9.2. DNA Synthesis
9.2.1. Primer Synthesis
9.2.2. Probe Synthesis
9.2.3. Synthetic Gene Synthesis
9.3. RNA Synthesis
9.3.1. miRNA Synthesis
9.3.2. mRNA Synthesis
9.3.3. siRNA Synthesis
9.4. Therapeutic Oligonucleotides
9.4.1. Antisense Oligonucleotides
9.4.2. Aptamer Development
9.4.3. siRNA Therapeutic
10. Automated Oligonucleotide Synthesizer Market, by Technology
10.1. Introduction
10.2. Enzymatic Synthesis
10.3. Phosphoramidite Synthesis
11. Automated Oligonucleotide Synthesizer Market, by End User
11.1. Introduction
11.2. Academic Institutions
11.3. Biotechnology Companies
11.4. Contract Manufacturing Organizations
11.5. Contract Research Organizations
11.6. Pharmaceutical Companies
12. Automated Oligonucleotide Synthesizer Market, by Scale
12.1. Introduction
12.2. Benchtop
12.3. High Throughput
13. Americas Automated Oligonucleotide Synthesizer Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Automated Oligonucleotide Synthesizer Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Automated Oligonucleotide Synthesizer Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Thermo Fisher Scientific Inc.
16.3.2. Merck KGaA
16.3.3. Agilent Technologies, Inc.
16.3.4. Tecan Group Ltd.
16.3.5. Hamilton Company, Inc.
16.3.6. Gilson, Inc.
16.3.7. BioAutomation, LLC.
16.3.8. Biosearch Technologies, Inc.
16.3.9. CEM Corporation
16.3.10. Hitachi High-Tech Corporation
17. ResearchAI18. ResearchStatistics19. ResearchContacts20. ResearchArticles21. Appendix
List of Figures
FIGURE 1. AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 8. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 10. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY SCALE, 2024 VS 2030 (%)
FIGURE 14. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY SCALE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET: RESEARCHAI
FIGURE 26. AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET: RESEARCHSTATISTICS
FIGURE 27. AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET: RESEARCHCONTACTS
FIGURE 28. AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY CONSUMABLES, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY PHOSPHORAMIDITES, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY PHOSPHORAMIDITES, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY REAGENTS SOLVENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY REAGENTS SOLVENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY SOLID SUPPORTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY SOLID SUPPORTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY CONSUMABLES, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY INSTRUMENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY BENCHTOP SYNTHESIZER, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY BENCHTOP SYNTHESIZER, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY HIGH THROUGHPUT SYNTHESIZER, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY HIGH THROUGHPUT SYNTHESIZER, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY SERVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY SERVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY CUSTOM SYNTHESIS SERVICE, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY CUSTOM SYNTHESIS SERVICE, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY MAINTENANCE SERVICE, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY MAINTENANCE SERVICE, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY TRAINING SERVICE, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY TRAINING SERVICE, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY DNA SYNTHESIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY DNA SYNTHESIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY PRIMER SYNTHESIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY PRIMER SYNTHESIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY PROBE SYNTHESIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY PROBE SYNTHESIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY SYNTHETIC GENE SYNTHESIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY SYNTHETIC GENE SYNTHESIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY DNA SYNTHESIS, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY DNA SYNTHESIS, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY RNA SYNTHESIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY RNA SYNTHESIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY MIRNA SYNTHESIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY MIRNA SYNTHESIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY MRNA SYNTHESIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY MRNA SYNTHESIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY SIRNA SYNTHESIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY SIRNA SYNTHESIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY RNA SYNTHESIS, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY RNA SYNTHESIS, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY THERAPEUTIC OLIGONUCLEOTIDES, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY THERAPEUTIC OLIGONUCLEOTIDES, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY ANTISENSE OLIGONUCLEOTIDES, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY ANTISENSE OLIGONUCLEOTIDES, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY APTAMER DEVELOPMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY APTAMER DEVELOPMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY SIRNA THERAPEUTIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY SIRNA THERAPEUTIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY THERAPEUTIC OLIGONUCLEOTIDES, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY THERAPEUTIC OLIGONUCLEOTIDES, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY ENZYMATIC SYNTHESIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY ENZYMATIC SYNTHESIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY PHOSPHORAMIDITE SYNTHESIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY PHOSPHORAMIDITE SYNTHESIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY ACADEMIC INSTITUTIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY ACADEMIC INSTITUTIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY CONTRACT MANUFACTURING ORGANIZATIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY CONTRACT MANUFACTURING ORGANIZATIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY SCALE, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY SCALE, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY BENCHTOP, BY REGION, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY BENCHTOP, BY REGION, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY HIGH THROUGHPUT, BY REGION, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY HIGH THROUGHPUT, BY REGION, 2025-2030 (USD MILLION)
TABLE 95. AMERICAS AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 96. AMERICAS AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 97. AMERICAS AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
TABLE 98. AMERICAS AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY CONSUMABLES, 2025-2030 (USD MILLION)
TABLE 99. AMERICAS AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 100. AMERICAS AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 101. AMERICAS AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
TABLE 102. AMERICAS AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
TABLE 103. AMERICAS AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 104. AMERICAS AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 105. AMERICAS AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY DNA SYNTHESIS, 2018-2024 (USD MILLION)
TABLE 106. AMERICAS AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY DNA SYNTHESIS, 2025-2030 (USD MILLION)
TABLE 107. AMERICAS AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY RNA SYNTHESIS, 2018-2024 (USD MILLION)
TABLE 108. AMERICAS AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY RNA SYNTHESIS, 2025-2030 (USD MILLION)
TABLE 109. AMERICAS AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY THERAPEUTIC OLIGONUCLEOTIDES, 2018-2024 (USD MILLION)
TABLE 110. AMERICAS AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY THERAPEUTIC OLIGONUCLEOTIDES, 2025-2030 (USD MILLION)
TABLE 111. AMERICAS AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 112. AMERICAS AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 113. AMERICAS AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 114. AMERICAS AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 115. AMERICAS AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY SCALE, 2018-2024 (USD MILLION)
TABLE 116. AMERICAS AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY SCALE, 2025-2030 (USD MILLION)
TABLE 117. AMERICAS AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 118. AMERICAS AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 119. UNITED STATES AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 120. UNITED STATES AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 121. UNITED STATES AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
TABLE 122. UNITED STATES AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY CONSUMABLES, 2025-2030 (USD MILLION)
TABLE 123. UNITED STATES AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 124. UNITED STATES AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 125. UNITED STATES AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
TABLE 126. UNITED STATES AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
TABLE 127. UNITED STATES AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 128. UNITED STATES AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 129. UNITED STATES AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY DNA SYNTHESIS, 2018-2024 (USD MILLION)
TABLE 130. UNITED STATES AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY DNA SYNTHESIS, 2025-2030 (USD MILLION)
TABLE 131. UNITED STATES AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY RNA SYNTHESIS, 2018-2024 (USD MILLION)
TABLE 132. UNITED STATES AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY RNA SYNTHESIS, 2025-2030 (USD MILLION)
TABLE 133. UNITED STATES AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY THERAPEUTIC OLIGONUCLEOTIDES, 2018-2024 (USD MILLION)
TABLE 134. UNITED STATES AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY THERAPEUTIC OLIGONUCLEOTIDES, 2025-2030 (USD MILLION)
TABLE 135. UNITED STATES AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 136. UNITED STATES AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 137. UNITED STATES AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 138. UNITED STATES AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 139. UNITED STATES AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY SCALE, 2018-2024 (USD MILLION)
TABLE 140. UNITED STATES AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY SCALE, 2025-2030 (USD MILLION)
TABLE 141. UNITED STATES AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 142. UNITED STATES AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 143. CANADA AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 144. CANADA AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 145. CANADA AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
TABLE 146. CANADA AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY CONSUMABLES, 2025-2030 (USD MILLION)
TABLE 147. CANADA AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 148. CANADA AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 149. CANADA AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
TABLE 150. CANADA AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
TABLE 151. CANADA AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 152. CANADA AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 153. CANADA AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY DNA SYNTHESIS, 2018-2024 (USD MILLION)
TABLE 154. CANADA AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY DNA SYNTHESIS, 2025-2030 (USD MILLION)
TABLE 155. CANADA AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY RNA SYNTHESIS, 2018-2024 (USD MILLION)
TABLE 156. CANADA AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY RNA SYNTHESIS, 2025-2030 (USD MILLION)
TABLE 157. CANADA AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY THERAPEUTIC OLIGONUCLEOTIDES, 2018-2024 (USD MILLION)
TABLE 158. CANADA AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY THERAPEUTIC OLIGONUCLEOTIDES, 2025-2030 (USD MILLION)
TABLE 159. CANADA AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 160. CANADA AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 161. CANADA AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 162. CANADA AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 163. CANADA AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY SCALE, 2018-2024 (USD MILLION)
TABLE 164. CANADA AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY SCALE, 2025-2030 (USD MILLION)
TABLE 165. MEXICO AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 166. MEXICO AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 167. MEXICO AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
TABLE 168. MEXICO AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY CONSUMABLES, 2025-2030 (USD MILLION)
TABLE 169. MEXICO AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 170. MEXICO AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 171. MEXICO AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
TABLE 172. MEXICO AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
TABLE 173. MEXICO AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 174. MEXICO AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 175. MEXICO AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY DNA SYNTHESIS, 2018-2024 (USD MILLION)
TABLE 176. MEXICO AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY DNA SYNTHESIS, 2025-2030 (USD MILLION)
TABLE 177. MEXICO AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY RNA SYNTHESIS, 2018-2024 (USD MILLION)
TABLE 178. MEXICO AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY RNA SYNTHESIS, 2025-2030 (USD MILLION)
TABLE 179. MEXICO AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY THERAPEUTIC OLIGONUCLEOTIDES, 2018-2024 (USD MILLION)
TABLE 180. MEXICO AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY THERAPEUTIC OLIGONUCLEOTIDES, 2025-2030 (USD MILLION)
TABLE 181. MEXICO AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 182. MEXICO AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 183. MEXICO AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 184. MEXICO AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 185. MEXICO AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY SCALE, 2018-2024 (USD MILLION)
TABLE 186. MEXICO AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY SCALE, 2025-2030 (USD MILLION)
TABLE 187. BRAZIL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 188. BRAZIL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 189. BRAZIL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
TABLE 190. BRAZIL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY CONSUMABLES, 2025-2030 (USD MILLION)
TABLE 191. BRAZIL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 192. BRAZIL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 193. BRAZIL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
TABLE 194. BRAZIL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
TABLE 195. BRAZIL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 196. BRAZIL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 197. BRAZIL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY DNA SYNTHESIS, 2018-2024 (USD MILLION)
TABLE 198. BRAZIL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY DNA SYNTHESIS, 2025-2030 (USD MILLION)
TABLE 199. BRAZIL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY RNA SYNTHESIS, 2018-2024 (USD MILLION)
TABLE 200. BRAZIL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY RNA SYNTHESIS, 2025-2030 (USD MILLION)
TABLE 201. BRAZIL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY THERAPEUTIC OLIGONUCLEOTIDES, 2018-2024 (USD MILLION)
TABLE 202. BRAZIL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY THERAPEUTIC OLIGONUCLEOTIDES, 2025-2030 (USD MILLION)
TABLE 203. BRAZIL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 204. BRAZIL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 205. BRAZIL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 206. BRAZIL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 207. BRAZIL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY SCALE, 2018-2024 (USD MILLION)
TABLE 208. BRAZIL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY SCALE, 2025-2030 (USD MILLION)
TABLE 209. ARGENTINA AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 210. ARGENTINA AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 211. ARGENTINA AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
TABLE 212. ARGENTINA AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY CONSUMABLES, 2025-2030 (USD MILLION)
TABLE 213. ARGENTINA AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 214. ARGENTINA AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 215. ARGENTINA AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
TABLE 216. ARGENTINA AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
TABLE 217. ARGENTINA AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 218. ARGENTINA AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 219. ARGENTINA AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY DNA SYNTHESIS, 2018-2024 (USD MILLION)
TABLE 220. ARGENTINA AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY DNA SYNTHESIS, 2025-2030 (USD MILLION)
TABLE 221. ARGENTINA AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY RNA SYNTHESIS, 2018-2024 (USD MILLION)
TABLE 222. ARGENTINA AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY RNA SYNTHESIS, 2025-2030 (USD MILLION)
TABLE 223. ARGENTINA AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY THERAPEUTIC OLIGONUCLEOTIDES, 2018-2024 (USD MILLION)
TABLE 224. ARGENTINA AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY THERAPEUTIC OLIGONUCLEOTIDES, 2025-2030 (USD MILLION)
TABLE 225. ARGENTINA AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 226. ARGENTINA AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 227. ARGENTINA AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 228. ARGENTINA AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 229. ARGENTINA AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY SCALE, 2018-2024 (USD MILLION)
TABLE 230. ARGENTINA AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY SCALE, 2025-2030 (USD MILLION)
TABLE 231. EUROPE, MIDDLE EAST & AFRICA AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 232. EUROPE, MIDDLE EAST & AFRICA AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 233. EUROPE, MIDDLE EAST & AFRICA AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
TABLE 234. EUROPE, MIDDLE EAST & AFRICA AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY CONSUMABLES, 2025-2030 (USD MILLION)
TABLE 235. EUROPE, MIDDLE EAST & AFRICA AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 236. EUROPE, MIDDLE EAST & AFRICA AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 237. EUROPE, MIDDLE EAST & AFRICA AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
TABLE 238. EUROPE, MIDDLE EAST & AFRICA AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
TABLE 239. EUROPE, MIDDLE EAST & AFRICA AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 240. EUROPE, MIDDLE EAST & AFRICA AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 241. EUROPE, MIDDLE EAST & AFRICA AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY DNA SYNTHESIS, 2018-2024 (USD MILLION)
TABLE 242. EUROPE, MIDDLE EAST & AFRICA AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY DNA SYNTHESIS, 2025-2030 (USD MILLION)
TABLE 243. EUROPE, MIDDLE EAST & AFRICA AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY RNA SYNTHESIS, 2018-2024 (USD MILLION)
TABLE 244. EUROPE, MIDDLE EAST & AFRICA AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY RNA SYNTHESIS, 2025-2030 (USD MILLION)
TABLE 245. EUROPE, MIDDLE EAST & AFRICA AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY THERAPEUTIC OLIGONUCLEOTIDES, 2018-2024 (USD MILLION)
TABLE 246. EUROPE, MIDDLE EAST & AFRICA AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY THERAPEUTIC OLIGONUCLEOTIDES, 2025-2030 (USD MILLION)
TABLE 247. EUROPE, MIDDLE EAST & AFRICA AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 248. EUROPE, MIDDLE EAST & AFRICA AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 249. EUROPE, MIDDLE EAST & AFRICA AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 250. EUROPE, MIDDLE EAST & AFRICA AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 251. EUROPE, MIDDLE EAST & AFRICA AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY SCALE, 2018-2024 (USD MILLION)
TABLE 252. EUROPE, MIDDLE EAST & AFRICA AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY SCALE, 2025-2030 (USD MILLION)
TABLE 253. EUROPE, MIDDLE EAST & AFRICA AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 254. EUROPE, MIDDLE EAST & AFRICA AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 255. UNITED KINGDOM AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 256. UNITED KINGDOM AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 257. UNITED KINGDOM AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
TABLE 258. UNITED KINGDOM AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY CONSUMABLES, 2025-2030 (USD MILLION)
TABLE 259. UNITED KINGDOM AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 260. UNITED KINGDOM AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 261. UNITED KINGDOM AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
TABLE 262. UNITED KINGDOM AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
TABLE 263. UNITED KINGDOM AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 264. UNITED KINGDOM AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 265. UNITED KINGDOM AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY DNA SYNTHESIS, 2018-2024 (USD MILLION)
TABLE 266. UNITED KINGDOM AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY DNA SYNTHESIS, 2025-2030 (USD MILLION)
TABLE 267. UNITED KINGDOM AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY RNA SYNTHESIS, 2018-2024 (USD MILLION)
TABLE 268. UNITED KINGDOM AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY RNA SYNTHESIS, 2025-2030 (USD MILLION)
TABLE 269. UNITED KINGDOM AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY THERAPEUTIC OLIGONUCLEOTIDES, 2018-2024 (USD MILLION)
TABLE 270. UNITED KINGDOM AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY THERAPEUTIC OLIGONUCLEOTIDES, 2025-2030 (USD MILLION)
TABLE 271. UNITED KINGDOM AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 272. UNITED KINGDOM AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 273. UNITED KINGDOM AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 274. UNITED KINGDOM AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 275. UNITED KINGDOM AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY SCALE, 2018-2024 (USD MILLION)
TABLE 276. UNITED KINGDOM AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY SCALE, 2025-2030 (USD MILLION)
TABLE 277. GERMANY AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 278. GERMANY AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 279. GERMANY AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
TABLE 280. GERMANY AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY CONSUMABLES, 2025-2030 (USD MILLION)
TABLE 281. GERMANY AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 282. GERMANY AUTOMATED OLIGONUCLEOTIDE SYN

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Automated Oligonucleotide Synthesizer market report include:
  • Thermo Fisher Scientific Inc.
  • Merck KGaA
  • Agilent Technologies, Inc.
  • Tecan Group Ltd.
  • Hamilton Company, Inc.
  • Gilson, Inc.
  • BioAutomation, LLC.
  • Biosearch Technologies, Inc.
  • CEM Corporation
  • Hitachi High-Tech Corporation